Evidence map›Paper›PMID 32270928›Full record

ReviewAdvanced healthcare materials2020

Mechanobiology Assays with Applications in Cardiomyocyte Biology and Cardiotoxicity.

Cheavar A Blair, Beth L Pruitt

Abstract readReview
In one paragraph

Review in Advanced healthcare materials, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Cheavar A BlairDepartment of Mechanical Engineering, University of California Santa Barbara, Santa Barbara, CA, 93109, USA.
Beth L PruittDepartment of Mechanical Engineering, University of California Santa Barbara, Santa Barbara, CA, 93109, USA.ORCID 0000-0002-4861-2124

Funding

From proteins to cells to tissues: A multi-scale assessment of biomechanical regulation by the myosin molecular motorRM1GM131981 · NIGMS · STANFORD UNIVERSITY · PI BERNSTEIN, DANIEL, MACK, DAVID LEE · 2019 to 2023
$10.3M
Effect of Microgravity on Drug Responses Using Engineered Heart TissuesUH3TR002588 · NCATS · STANFORD UNIVERSITY · PI PRUITT, BETH L, WU, JOSEPH C. · 2020 to 2022
$1.6M
Effect of Microgravity on Drug Responses Using Engineered Heart TissuesUG3TR002588 · NCATS · STANFORD UNIVERSITY · PI PRUITT, BETH L, WU, JOSEPH C. · 2018 to 2019
$1.5M
Validating engineered hiPSC-derived cardiomyocytes as model cellsR21HL130993 · NHLBI · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI PRUITT, BETH L · 2016 to 2017
$434k
NCATS NIH HHS UG3 TR002588NCATS NIH HHS UH3 TR002588NHLBI NIH HHS R21 HL130993NIGMS NIH HHS RM1 GM131981
6 · The paper itself

Abstract

Cardiomyocytes are the motor units that drive the contraction and relaxation of the heart. Traditionally, testing of drugs for cardiotoxic effects has relied on primary cardiomyocytes from animal models and focused on short-term, electrophysiological, and arrhythmogenic effects. However, primary cardiomyocytes present challenges arising from their limited viability in culture, and tissue from animal models suffers from a mismatch in their physiology to that of human heart muscle. Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) can address these challenges. They also offer the potential to study not only electrophysiological effects but also changes in cardiomyocyte contractile and mechanical function in response to cardiotoxic drugs. With growing recognition of the long-term cardiotoxic effects of some drugs on subcellular structure and function, there is increasing interest in using hiPSC-CMs for in vitro cardiotoxicity studies. This review provides a brief overview of techniques that can be used to quantify changes in the active force that cardiomyocytes generate and variations in their inherent stiffness in response to cardiotoxic drugs. It concludes by discussing the application of these tools in understanding how cardiotoxic drugs directly impact the mechanobiology of cardiomyocytes and how cardiomyocytes sense and respond to mechanical load at the cellular level.

Indexed as

Induced Pluripotent Stem CellsMyocytes, CardiacAnimalsBiologyBiophysicsCardiotoxicityHumanscardiomyocytescardiotoxicityheart failurehuman induced pluripotent stem cellsmechanobiologymechanotransduction

Identifiers

PMID32270928
PMCPMC7480481

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.